Massive and long-lasting decrease in vitamin C plasma levels as a consequence of extracorporeal circulation

Nutrition

Volumn 30, Issue 6, 2014, Pages 673-678

  Rodemeister, Sandra ^a   Duquesne, Mathieu ^b   Adolph, Michael ^c   Nohr, Donatus ^a   Biesalski, Hans K ^a   Unertl, Klaus ^c  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antioxidants; Ascorbic acid; Ascorbyl free radical; Cardiopulmonary bypass; Cardiovascular surgery; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ASCORBYL FREE RADICAL; FREE RADICAL; MALONALDEHYDE; UNCLASSIFIED DRUG; DEHYDROASCORBIC ACID; REACTIVE OXYGEN METABOLITE; SEMIDEHYDROASCORBIC ACID;

AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CLINICAL ARTICLE; CONVALESCENCE; ELECTRON SPIN RESONANCE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL DISCHARGE; HUMAN; MALE; MALONDIALDEHYDE BLOOD LEVEL; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION; VITAMIN BLOOD LEVEL; ADULT; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASES; DRUG EFFECTS; METABOLISM; MIDDLE AGED; TIME;

ADULT; AGED; ANTIOXIDANTS; ASCORBIC ACID; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEHYDROASCORBIC ACID; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TIME FACTORS; VITAMIN E;

EID: 84899926009     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.10.026     Document Type: Article

References (48)

1. Murphy G.J., Angelini G.D. Side effects of cardiopulmonary bypass: what is the reality?. J Card Surg 2004, 19:481-488.
2. Paparella D., Yau T.M., Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002, 21:232-244.
3. Carden D.L., Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000, 190:255-266.
4. Rodrigo R., Cereceda M., Castillo R., Asenjo R., Zamorano J., Araya J., et al. Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol Ther 2008, 118:104-127.
5. Baker W.L., White C.M. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother 2007, 41:587-598.
6. Ramlawi B., Otu H., Mieno S., Boodhwani M., Sodha N.R., Clements R.T., et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 2007, 84:1166-1172. discussion 1172-3.
7. Korantzopoulos P., Kolettis T.M., Galaris D., Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007, 115:135-143.
8. Day J.R., Taylor K.M. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 2005, 3:129-140.
9. Kim Y.M., Guzik T.J., Zhang Y.H., Zhang M.H., Kattach H., Ratnatunga C., et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005, 97:629-636.
10. Wan S., LeClerc J.L., Vincent J.L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997, 112:676-692.
11. Wildhirt S.M., Schulze C., Schulz C., Egi K., Brenner P., Mair H., et al. Reduction of systemic and cardiac adhesion molecule expression after off-pump versus conventional coronary artery bypass grafting. Shock 2001, 16(Suppl 1):55-59.
12. Matata B.M., Sosnowski A.W., Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 2000, 69:785-791.
13. Rodrigo R., Guichard C., Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 2007, 21:111-127.
14. McGregor G.P., Biesalski H.K. Rationale and impact of vitamin C in clinical nutrition. Curr Opin Clin Nutr Metab Care 2006, 9:697-703.
15. Alonso de Vega J.M., Diaz J., Serrano E., Carbonell L.F. Plasma redox status relates to severity in critically ill patients. Crit Care Med 2000, 28:1812-1814.
16. Borrelli E., Roux-Lombard P., Grau G.E., Girardin E., Ricou B., Dayer J., et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996, 24:392-397.
17. Cavalca V., Sisillo E., Veglia F., Tremoli E., Cighetti G., Salvi L., et al. Isoprostanes and oxidative stress in off-pump and on-pump coronary bypass surgery. Ann Thorac Surg 2006, 81:562-567.
18. De Vecchi E., Pala M.G., Di Credico G., Agape V., Paolini G., Bonini P.A., et al. Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart 1998, 79:242-247.
19. Westhuyzen J., Cochrane A.D., Tesar P.J., Mau T., Cross D.B., Frenneaux M.P., et al. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1997, 113:942-948.
20. Davies S.W., Duffy J.P., Wickens D.G., Underwood S.M., Hill A., Alladine M.F., et al. Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993, 105:979-987.
21. Sharma M., Ganguly N.K., Chaturvedi G., Thingnam S.K., Majumdar S., Suri R.K. Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery. Mol Cell Biochem 2003, 247:23-30.
22. Luyten C.R., van Overveld F.J., De Backer L.A., Sadowska A.M., Rodrigus I.E., De Hert S.G., et al. Antioxidant defense during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg 2005, 27:611-616.
23. Wong S.H., Knight J.A., Hopfer S.M., Zaharia O., Leach C.N., Sunderman F.W. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987, 33:214-220.
24. Christen S., Finckh B., Lykkesfeldt J., Gessler P., Frese-Schaper M., Nielsen P., et al. Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation. Free Radic Biol Med 2005, 38:1323-1332.
25. Ballmer P.E., Reinhart W.H., Jordan P., Buhler E., Moser U.K., Gey K.F. Depletion of plasma vitamin C but not of vitamin E in response to cardiac operations. J Thorac Cardiovasc Surg 1994, 108:311-320.
26. Valle-Giner I., Marti-Bonmati E., Alegria-Toran A., Montero A., Morcillo E.J. Changes in alpha-tocopherol and retinol levels during cardiopulmonary bypass correlate with maximal arterial partial pressure of oxygen. Free Radic Res 2007, 41:1061-1067.
27. Tangney C.C., Hankins J.S., Murtaugh M.A., Piccione W. Plasma vitamins E and C concentrations of adult patients during cardiopulmonary bypass. J Am Coll Nutr 1998, 17:162-170.
28. Lassnigg A., Punz A., Barker R., Keznickl P., Manhart N., Roth E., et al. Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth 2003, 90:148-154.
29. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 2000, 23:209-216.
30. Hornig D. Distribution of ascorbic acid, metabolites and analogues in man and animals. Ann N Y Acad Sci 1975, 258:103-118.
31. May J.M., Huang J., Qu Z.C. Macrophage uptake and recycling of ascorbic acid: response to activation by lipopolysaccharide. Free Radic Biol Med 2005, 39:1449-1459.
32. Duncan A., Talwar D., McMillan D.C., Stefanowicz F., O'Reilly D.S. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr 2012, 95:64-71.
33. May J.M., Li L., Qu Z.C., Cobb C.E. Mitochondrial recycling of ascorbic acid as a mechanism for regenerating cellular ascorbate. Biofactors 2007, 30:35-48.
34. May J.M., Qu Z.C., Neel D.R., Li X. Recycling of vitamin C from its oxidized forms by human endothelial cells. Biochim Biophys Acta 2003, 1640:153-161.
35. May J.M., Qu Z., Morrow J.D. Mechanisms of ascorbic acid recycling in human erythrocytes. Biochim Biophys Acta 2001, 1528:159-166.
36. May J.M., Mendiratta S., Hill K.E., Burk R.F. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem 1997, 272:22607-22610.
37. Muhlhofer A., Mrosek S., Schlegel B., Trommer W., Rozario F., Bohles H., et al. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers. Eur J Clin Nutr 2004, 58:1151-1158.
38. Galley H.F., Davies M.J., Webster N.R. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med 1996, 20:139-143.
39. Guvener M., Ucar I., Ozkan M., Dogan O.F., Serter F.T., Pasaoglu I. Effect of cardiopulmonary bypass on plasma levels of lipoprotein (a) in hypercholesterolemic patients. Jpn Heart J 2001, 42:563-574.
40. Sgoutas D.S., Lattouf O.M., Finlayson D.C., Clark R.V. Paradoxical response of plasma lipoprotein(a) in patients undergoing cardiopulmonary bypass. Atherosclerosis 1992, 97:29-36.
41. Atkinson J., Epand R.F., Epand R.M. Tocopherols and tocotrienols in membranes: a critical review. Free Radic Biol Med 2008, 44:739-764.
42. Fukuzawa K. Dynamics of lipid peroxidation and antioxidion of alpha-tocopherol in membranes. J Nutr Sci Vitaminol (Tokyo) 2008, 54:273-285.
43. Traber M.G., Stevens J.F. Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med 2011, 51:1000-1013.
44. Schorah C.J., Downing C., Piripitsi A., Gallivan L., Al-Hazaa A.H., Sanderson M.J., et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996, 63:760-765.
45. Cowley H.C., Bacon P.J., Goode H.F., Webster N.R., Jones J.G., Menon D.K. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 1996, 24:1179-1183.
46. Giladi A.M., Dossett L.A., Fleming S.B., Abumrad N.N., Cotton B.A. High-dose antioxidant administration is associated with a reduction in post-injury complications in critically ill trauma patients. Injury 2011, 42:78-82.
47. Nathens A.B., Neff M.J., Jurkovich G.J., Klotz P., Farver K., Ruzinski J.T., et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002, 236:814-822.
48. Long C.L., Maull K.I., Krishnan R.S., Laws H.L., Geiger J.W., Borghesi L., et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003, 109:144-148.